Craig D McColl
Overview
Explore the profile of Craig D McColl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagao K, Ding C, Ganga G, Alty J, Clissold B, McColl C, et al.
Parkinsonism Relat Disord
. 2018 Sep;
60:133-137.
PMID: 30217541
Introduction: The long duration response to levodopa in Parkinson's disease outlasts drug elimination by days to weeks. Though a substantive part of anti-parkinsonian motor benefit, it cannot easily be observed....
2.
Ding C, Ganesvaran G, Alty J, Clissold B, McColl C, Reardon K, et al.
Mov Disord
. 2016 Feb;
31(4):589-92.
PMID: 26873476
Introduction: It is important to understand how the rate of motor progression in PD relates to dopaminergic treatment. Methods: The methods for this study comprised prospective defined off state measurements...
3.
Ganga G, Alty J, Clissold B, McColl C, Reardon K, Schiff M, et al.
Mov Disord
. 2013 Feb;
28(4):476-81.
PMID: 23390112
Thirty-four patients have been studied from the time of initiation of pharmacological treatment in a long-term prospective study of levodopa effects and disease progression in Parkinson's disease. Objective motor scoring...
4.
Alty J, Clissold B, McColl C, Reardon K, Shiff M, Kempster P
Mov Disord
. 2009 Nov;
24(16):2337-43.
PMID: 19890972
In this prospective study of 34 patients with Parkinson's disease (PD), measurements of the short duration levodopa motor response have been performed every 3 years in defined off states. The...
5.
Clissold B, McColl C, Reardon K, Shiff M, Kempster P
Mov Disord
. 2006 Oct;
21(12):2116-21.
PMID: 17029259
In this prospective study of 34 patients with Parkinson's disease, measurements of the short duration levodopa motor response have been performed in defined off states at 3 yearly intervals over...
6.
McColl C, Jacoby A, Shine J, Iismaa T, Bekkers J
Neuropharmacology
. 2005 Oct;
50(2):209-18.
PMID: 16243364
Galanin is a widely-distributed neuropeptide that acts as an endogenous anticonvulsant. We have recently generated a galanin receptor type 1 knockout mouse (Galr1(-/-)) that develops spontaneous seizures. Our aim here...
7.
McColl C, Reardon K, Shiff M, Kempster P
Mov Disord
. 2002 Dec;
17(6):1227-34.
PMID: 12465061
Thirty-four patients with Parkinson's disease were followed for a mean period of 8 years from the time of initiation of levodopa medication. Levodopa response was charted from the starting point...